Membranous glomerulonephritis classification: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Anmol Pitliya (talk | contribs)
Bureaucrats, bureaucrats, nocaptcha, Administrators, Widget editors
9,217 edits
No edit summary
Sunny Kumar (talk | contribs)
nocaptcha
967 edits
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}  
==Overview==
==Overview==
There is no established system for the classification of [disease name].
There is no established system for the classification of MGN. however it can be divided in two groups based on etiology of MGN.
 
OR
 
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
 
OR
 
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
[Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
 
OR
 
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
 
OR
 
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
 
OR
 
The staging of [malignancy name] is based on the [staging system].
 
OR
 
There is no established system for the staging of [malignancy name].


==Classification==
==Classification==


*There is no established system for the classification of [disease name].
*There is no established system for the classification of MGN. however it can be divided in two groups based on etiology of MGN.
OR
{| class="wikitable"
*[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
!TYPE
**[Group1]
!Type of Ig
**[Group2]
!Anti-Human phospholipase A2 receptor
**[Group3]
!Routine cancer screening
**[Group4]
|-
OR
|Idiopathic
*[Disease name] may be classified into [large number > 6] subtypes based on:
|IgG4
**[Classification method 1]
|Postive
**[Classification method 2]
|Not recommended
**[Classification method 3]
|-
*[Disease name] may be classified into several subtypes based on:
|Secondary
**[Classification method 1]
|IgG1, IgG2, IgG3
**[Classification method 2]
|Negative
**[Classification method 3]
|Recommended
OR
|}
*Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
*If the staging system involves specific and characteristic findings and features:
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
*The staging of [malignancy name] is based on the [staging system].
OR
*There is no established system for the staging of [malignancy name].


==References==
==References==

Revision as of 18:38, 16 June 2018

Membranous glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Membranous glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Membranous glomerulonephritis classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Membranous glomerulonephritis classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Membranous glomerulonephritis classification

CDC on Membranous glomerulonephritis classification

Membranous glomerulonephritis classification in the news

Blogs on Membranous glomerulonephritis classification

Directions to Hospitals Treating Membranous glomerulonephritis

Risk calculators and risk factors for Membranous glomerulonephritis classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is no established system for the classification of MGN. however it can be divided in two groups based on etiology of MGN.

Classification

  • There is no established system for the classification of MGN. however it can be divided in two groups based on etiology of MGN.
TYPE Type of Ig Anti-Human phospholipase A2 receptor Routine cancer screening
Idiopathic IgG4 Postive Not recommended
Secondary IgG1, IgG2, IgG3 Negative Recommended

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Membranous_glomerulonephritis_classification&oldid=1477432"